UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 601

Sortiert nach

Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus

Lupus, 2013-02, Vol.22 (2), p.144-154

2013

Link zum Volltext

Verfügbarkeit prüfen

Celecoxib Versus Naproxen and Diclofenac in Osteoarthritis Patients: SUCCESS-I Study

The American journal of medicine, 2006-03, Vol.119 (3), p.255-266

2006

Link zum Volltext

Verfügbarkeit prüfen

Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study

Lupus, 2001-06, Vol.10 (6), p.401-404

2001

Link zum Volltext

Verfügbarkeit prüfen

PO.5.102 Pharmacokinetic modelling of belimumab in patients with lupus nephritis: intravenous and subcutaneous loading dose regimen justification

Lupus science & medicine, 2022-10, Vol.9 (Suppl 2), p.A80-A81

2022

Link zum Volltext

Verfügbarkeit prüfen

PO.5.101 The effect of belimumab on renal outcomes in a pre-specified subgroup analysis of a phase 3 randomised trial in a european population with lupus nephritis

Lupus science & medicine, 2022-10, Vol.9 (Suppl 2), p.A79-A80

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

The Lancet (British edition), 2011, Vol.377 (9767), p.721-731

2011

Link zum Volltext

Verfügbarkeit prüfen

14th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends

Autoimmunity reviews, 2014-06, Vol.13 (6), p.685-696

2014

Link zum Volltext

Verfügbarkeit prüfen

Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials

Annals of the rheumatic diseases, 2014-05, Vol.73 (5), p.838-844

2014

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of belimumab on renal outcomes in patients with systemic lupus erythematosus: A systematic review

Autoimmunity reviews, 2017-03, Vol.16 (3), p.287-293

2017

Link zum Volltext

Verfügbarkeit prüfen

Drug delivery systems improve pharmaceutical profile and facilitate medication adherence

Advances in therapy, 2005-11, Vol.22 (6), p.559-577

2005

Link zum Volltext

Verfügbarkeit prüfen

Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study

BJOG : an international journal of obstetrics and gynaecology, 2019-04, Vol.126 (5), p.656-661

2019

Link zum Volltext

Verfügbarkeit prüfen

Immunology of pregnancy and reproductive health in autoimmune rheumatic diseases. Update from the 11th International Conference on Reproduction, Pregnancy and Rheumatic Diseases

Autoimmunity reviews, 2023-03, Vol.22 (3), p.103259, Article 103259

2023

Link zum Volltext

Verfügbarkeit prüfen

Patient–health care provider relationship: how can it impact on APS (Hughes’ syndrome) adherence to treatment?

Lupus, 2014-10, Vol.23 (12), p.1265-1268

2014

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma in a Diverse and Underserved Population in the United States

Journal of hepatocellular carcinoma, 2024-01, Vol.11, p.257-269

2024

Link zum Volltext

Verfügbarkeit prüfen

Electrostatic flexible film based smart window: Optical design, performance and residual charge investigation

Solar energy, 2014-12, Vol.110, p.667-672

2014

Link zum Volltext

Verfügbarkeit prüfen

The use of angiogenic and antiangiogenic factors in the differential diagnosis of pre-eclampsia, antiphospholipid syndrome nephropathy and lupus nephritis

Lupus, 2014-10, Vol.23 (12), p.1299-1301

2014

Link zum Volltext

Verfügbarkeit prüfen

Racial and ethnic differences in response to medicines: Towards individualized pharmaceutical treatment

Journal of the National Medical Association, 2002-10, Vol.94 (10), p.1-26

2002

Link zum Volltext

Verfügbarkeit prüfen

Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients

Medicine (Baltimore), 1998-05, Vol.77 (3), p.195-207

1998

Link zum Volltext

Verfügbarkeit prüfen

Using the GRADE system in diagnostic strategy: the case of antiphospholipid syndrome

Lupus, 2014-10, Vol.23 (12), p.1292-1294

2014

Link zum Volltext

Verfügbarkeit prüfen

Relevance of different results of different anti-double-stranded DNA assays in reporting clinical studies: comment on the article by Petri et al. Reply

Arthritis & rheumatology (Hoboken, N.J.), 2014-02, Vol.66 (2), p.480-480

2014

Link zum Volltext

Verfügbarkeit prüfen

SAT0204 Predictors for SLE flares: Baseline disease activity and demographic characteristics from the bliss trials’ combined placebo groups

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.540-541

2013

Link zum Volltext

Verfügbarkeit prüfen

SAT0197 Baseline laboratory characteristics from the combined placebo groups in the bliss trials are predictive of severe flare at 24 weeks

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.538-538

2013

Link zum Volltext

Verfügbarkeit prüfen

Obstetric antiphospholipid syndrome: still a challenge

Lupus, 2010-04, Vol.19 (4), p.457-459

2010

Link zum Volltext

Verfügbarkeit prüfen

An image‐based approach for designing and manufacturing craniofacial scaffolds

International journal of oral and maxillofacial surgery, 2000-02, Vol.29 (1), p.67-71

2000

Link zum Volltext

Verfügbarkeit prüfen

Management of Obstetric Antiphospholipid Syndrome

Current rheumatology reports, 2012-02, Vol.14 (1), p.79-86

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 601

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(509)
Mit Volltextzugriff
(481)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(601)
Japanisch
(74)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus

Celecoxib Versus Naproxen and Diclofenac in Osteoarthritis Patients: SUCCESS-I Study

Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study

PO.5.102 Pharmacokinetic modelling of belimumab in patients with lupus nephritis: intravenous and subcutaneous loading dose regimen justification

PO.5.101 The effect of belimumab on renal outcomes in a pre-specified subgroup analysis of a phase 3 randomised trial in a european population with lupus nephritis

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

14th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends

Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials

Efficacy of belimumab on renal outcomes in patients with systemic lupus erythematosus: A systematic review

Drug delivery systems improve pharmaceutical profile and facilitate medication adherence

Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study

Immunology of pregnancy and reproductive health in autoimmune rheumatic diseases. Update from the 11th International Conference on Reproduction, Pregnancy and Rheumatic Diseases

Patient–health care provider relationship: how can it impact on APS (Hughes’ syndrome) adherence to treatment?

Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma in a Diverse and Underserved Population in the United States

Electrostatic flexible film based smart window: Optical design, performance and residual charge investigation

The use of angiogenic and antiangiogenic factors in the differential diagnosis of pre-eclampsia, antiphospholipid syndrome nephropathy and lupus nephritis

Racial and ethnic differences in response to medicines: Towards individualized pharmaceutical treatment

Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients

Using the GRADE system in diagnostic strategy: the case of antiphospholipid syndrome

Relevance of different results of different anti-double-stranded DNA assays in reporting clinical studies: comment on the article by Petri et al. Reply

SAT0204 Predictors for SLE flares: Baseline disease activity and demographic characteristics from the bliss trials’ combined placebo groups

SAT0197 Baseline laboratory characteristics from the combined placebo groups in the bliss trials are predictive of severe flare at 24 weeks

Obstetric antiphospholipid syndrome: still a challenge

An image‐based approach for designing and manufacturing craniofacial scaffolds

Management of Obstetric Antiphospholipid Syndrome

Suchergebnisse filtern